Diagnosis, Testing, and Ruling Out Other Causes
At a Glance
Alcoholic cardiomyopathy is diagnosed by combining evidence of an enlarged, weak heart with a significant alcohol-use history and by ruling out other causes. Echocardiography, cardiac MRI, blood tests, and sometimes genetic testing help complete the evaluation.
Diagnosing alcoholic cardiomyopathy (ACM) is often a process of elimination. Because the symptoms of ACM—like fatigue and shortness of breath—are identical to those caused by clogged arteries or viral infections, your doctors must work backward to rule out other causes before confirming ACM [1]. This process is known as a diagnosis of exclusion [2].
Ruling Out Other Causes
To confirm ACM, your care team needs to ensure that your heart muscle weakness isn’t caused by something else. They will typically look for three things:
- Dilation and Weakness: Evidence that your heart chambers are enlarged and pumping poorly [1].
- Alcohol History: A significant history of alcohol use, often historically defined as more than 80 grams of ethanol (about 5 to 6 drinks) daily for at least five years, though this is a research convention and can vary based on individual sensitivity [3][1].
- No Other Explanation: Ruling out ischemic heart disease (blocked arteries), primary valve disease, active viral myocarditis (inflammation of the heart muscle), tachycardia-mediated cardiomyopathy, uncontrolled hypertension, thyroid or other endocrine disorders, nutritional deficiency, stimulant or chemotherapy exposure, and familial DCM [1][4].
Key Diagnostic Tests
Your doctor will use several specialized tests to look at the structure, function, and “scars” of your heart.
- Echocardiogram (Echo): This is usually the first test. It uses sound waves to create a real-time video of your heart. It measures your Ejection Fraction (EF)—the percentage of blood your heart pumps out with each beat—and can detect “subclinical” damage through strain analysis, which looks at how well the heart muscle fibers stretch and contract [5][6].
- Cardiac MRI (CMR): This provides the most detailed look at your heart tissue. Doctors look for Late Gadolinium Enhancement (LGE), which identifies areas of fibrosis (scarring) or inflammation [5]. In ACM, this scarring is often found in the mid-wall or the septum (the wall between the chambers). This helps distinguish it from a heart attack, where scarring usually starts on the inner lining, though this pattern can overlap with genetic DCM, myocarditis, and sarcoidosis [6][7].
- Blood Biomarkers:
- NT-proBNP: A protein released when the heart is under “stretch” or stress. It helps measure the severity of your heart failure, but it is influenced by age, kidney function, and atrial fibrillation, so there is not one universal treatment target [8].
- Troponins: These are released when heart cells are damaged. High levels might suggest a recent “hit” to the heart or inflammation like myocarditis [9].
- Liver Enzymes: Because alcohol affects the liver, these nonspecific tests help your doctor understand the overall impact of alcohol on your body [1].
The Role of Genetic Testing
In the past, ACM was blamed entirely on alcohol. However, we now know that some people with ACM carry a genetic variant—most commonly in the titin (TTN) gene—that makes their heart muscle more vulnerable to toxic substances [10][11].
Genetic counseling and a multigene cardiomyopathy panel may be considered, particularly with a family history, young age, unexplained or persistent dysfunction, or features suggesting inherited dilated cardiomyopathy. Identifying a pathogenic variant is important because it may guide how your doctor screens your family members [12]. Keep in mind that a Variant of Uncertain Significance (VUS) should not be used to label relatives or direct their care. Pre- and post-test genetic counseling is highly important.
Your Diagnostic Checklist
When you receive your test results, look for these specific measurements, keeping in mind that your clinicians will interpret them based on the whole clinical picture:
| Measurement | What it Means |
|---|---|
| LVEF | Left Ventricular Ejection Fraction: A measure of how much blood the main chamber pumps out. Normal LVEF ranges vary by modality, laboratory, and patient characteristics [5]. |
| LV End-Diastolic Volume | How much the heart chamber stretches when it is full of blood. This should be interpreted using indexed values and sex/body size [7]. |
| LGE Pattern | Late Gadolinium Enhancement: Shows where scar tissue or active inflammatory injury is located. ACM often shows a “mid-wall” or “septal” pattern, though absence of LGE does not exclude disease [6]. |
| Global Longitudinal Strain | A measure of how the muscle fibers deform; it has method- and vendor-dependent reference ranges [5]. |
| NT-proBNP Level | A blood marker for heart “stress.” Trends over time are key, as isolated numbers depend on many factors [8]. |
| TTN Status | Whether genetic testing found a variant in the titin gene [10]. |
Common questions in this guide
How do doctors diagnose alcoholic cardiomyopathy?
Which tests can help identify alcoholic cardiomyopathy?
What does a cardiac MRI show in alcoholic cardiomyopathy?
Can a TTN gene variant affect my diagnosis or my family?
What does my NT-proBNP result mean?
How much does my alcohol history matter when evaluating this condition?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.Based on my imaging, what was the specific pattern of scarring (LGE), and does it confirm that my heart failure is non-ischemic?
- 2.What is my current 'dry weight' for monitoring, and how did my NT-proBNP level compare to my previous trends?
- 3.Given the role of genetics in this condition, do you consider a multigene panel for dilated cardiomyopathy to be appropriate for me?
- 4.Since some vitamins are poorly absorbed with alcohol, have you checked my thiamine (vitamin B1) levels?
- 5.If my genetic testing reveals a titin (TTN) variant, what does that mean for my siblings or children?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
References
References (12)
- 1
Alcoholic cardiomyopathy: an update.
Domínguez F, Adler E, García-Pavía P
European heart journal 2024; (45(26)):2294-2305 doi:10.1093/eurheartj/ehae362.
PMID: 38848133 - 2
Dilated cardiomyopathy: causes, mechanisms, and current and future treatment approaches.
Heymans S, Lakdawala NK, Tschöpe C, Klingel K
Lancet (London, England) 2023; (402(10406)):998-1011 doi:10.1016/S0140-6736(23)01241-2.
PMID: 37716772 - 3
Quantifying the contribution of alcohol to cardiomyopathy: A systematic review.
Rehm J, Hasan OSM, Imtiaz S, Neufeld M
Alcohol (Fayetteville, N.Y.) 2017; (61()):9-15 doi:10.1016/j.alcohol.2017.01.011.
PMID: 28599715 - 4
Dilated cardiomyopathy.
Schultheiss HP, Fairweather D, Caforio ALP, et al.
Nature reviews. Disease primers 2019; (5(1)):32 doi:10.1038/s41572-019-0084-1.
PMID: 31073128 - 5
Current diagnostic strategies for dilated cardiomyopathy: a comparison of imaging techniques.
Porcari A, De Angelis G, Romani S, et al.
Expert review of cardiovascular therapy 2019; (17(1)):53-63 doi:10.1080/14779072.2019.1550719.
PMID: 30457393 - 6
Distinct CMR Phenotype in Alcoholic Cardiomyopathy: Greater Myocardial Fibrosis and Right Ventricular Dysfunction Compared with Idiopathic Dilated Cardiomyopathy.
Vallejo-García V, Barreiro-Pérez M, González-Calle D, et al.
Diagnostics (Basel, Switzerland) 2026; (16(10)) doi:10.3390/diagnostics16101560.
PMID: 42196926 - 7
The alcohol-induced cardiomyopathy: A cardiovascular magnetic resonance characterization.
Artico J, Merlo M, Asher C, et al.
International journal of cardiology 2021; (331()):131-137 doi:10.1016/j.ijcard.2021.01.067.
PMID: 33545263 - 8
The Time Has Come to Explore Plasma Biomarkers in Genetic Cardiomyopathies.
Stege NM, de Boer RA, van den Berg MP, Silljé HHW
International journal of molecular sciences 2021; (22(6)) doi:10.3390/ijms22062955.
PMID: 33799487 - 9
Revisiting Secondary Dilative Cardiomyopathy.
Kundnani NR, Di Luca F, Meche V, et al.
International journal of molecular sciences 2025; (26(9)) doi:10.3390/ijms26094181.
PMID: 40362416 - 10
Genetic Etiology for Alcohol-Induced Cardiac Toxicity.
Ware JS, Amor-Salamanca A, Tayal U, et al.
Journal of the American College of Cardiology 2018; (71(20)):2293-2302 doi:10.1016/j.jacc.2018.03.462.
PMID: 29773157 - 11
Second Hits in Dilated Cardiomyopathy.
Marstrand P, Picard K, Lakdawala NK
Current cardiology reports 2020; (22(2)):8 doi:10.1007/s11886-020-1260-3.
PMID: 31980956 - 12
Evolving Approaches to Genetic Evaluation of Specific Cardiomyopathies.
Teo LY, Moran RT, Tang WH
Current heart failure reports 2015; (12(6)):339-49 doi:10.1007/s11897-015-0271-7.
PMID: 26472190
This page is for informational purposes only and does not constitute medical advice. Your cardiologist should interpret your imaging, blood tests, alcohol history, and genetic results in the context of your overall health.
Get notified when new evidence is published on alcoholic cardiomyopathy.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.